Cargando…
LncRNA CBR3-AS1 promotes osteosarcoma progression through the network of miR-140-5p/DDX54-NUCKS1-mTOR signaling pathway
Long noncoding RNA (lncRNA) CBR3-AS1 (termed as CBR3-AS1) has been reported to be upregulated in several cancers including osteosarcoma. Its positive impact on the proliferation, migration, and invasion of osteosarcoma cells has been unveiled; nevertheless, whether it also affects the stemness and e...
Autores principales: | Yao, Weitao, Hou, Jingyu, Liu, Guoqing, Wu, Fangxing, Yan, Qiang, Guo, Liangyu, Wang, Chuchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092395/ https://www.ncbi.nlm.nih.gov/pubmed/35592388 http://dx.doi.org/10.1016/j.omto.2022.03.001 |
Ejemplares similares
-
NUCKS1 promotes RAD54 activity in homologous recombination DNA repair
por: Maranon, David G., et al.
Publicado: (2020) -
NUCKS promotes cell proliferation and suppresses autophagy through the mTOR-Beclin1 pathway in gastric cancer
por: Zhao, Erhu, et al.
Publicado: (2020) -
Scars on the CBR?
por: Cohen, Andrew G, et al.
Publicado: (1997) -
Experimental Study of Somatic Variants of Osteosarcoma by Whole-Exome Sequencing
por: Hou, Jingyu, et al.
Publicado: (2020) -
mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)